Terms: = Kidney tumors AND Ki-67 AND Staging
16 results:
1. Current methods facilitating diagnosis of upper tract urothelial carcinoma: a comprehensive literature review.
Krajewski W; Łaszkiewicz J; Nowak Ł; Szydełko T
Curr Opin Urol; 2023 May; 33(3):230-238. PubMed ID: 36727755
[TBL] [Abstract] [Full Text] [Related]
2. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
[TBL] [Abstract] [Full Text] [Related]
3. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center.
Li S; Feng X; Li T; Zhang S; Zuo Z; Lin P; Konoplev S; Bueso-Ramos CE; Vega F; Medeiros LJ; Yin CC
Am J Surg Pathol; 2013 Jan; 37(1):14-23. PubMed ID: 23232851
[TBL] [Abstract] [Full Text] [Related]
4. Biomarkers in renal cell carcinoma.
McGuire BB; Fitzpatrick JM
Curr Opin Urol; 2009 Sep; 19(5):441-6. PubMed ID: 19584732
[TBL] [Abstract] [Full Text] [Related]
5. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.
Pinto AE; Monteiro P; Silva G; Ayres JV; Soares J
Int J Biol Markers; 2005; 20(4):249-56. PubMed ID: 16398407
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of the expression of ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
[TBL] [Abstract] [Full Text] [Related]
10. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract] [Full Text] [Related]
11. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract] [Full Text] [Related]
12. Histopathologic prognostic indicators for renal cell carcinoma.
Delahunt B
Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
[TBL] [Abstract] [Full Text] [Related]
14. Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?
Haitel A; Wiener HG; Migschitz B; Marberger M; Susani M
Am J Clin Pathol; 1997 Feb; 107(2):229-35. PubMed ID: 9024073
[TBL] [Abstract] [Full Text] [Related]
15. Correlation between DNA ploidy, proliferation marker ki-67 and early tumor progression in renal cell carcinoma. A prospective study.
Papadopoulos I; Weichert-Jacobsen K; Wacker HH; Sprenger E
Eur Urol; 1997; 31(1):49-53. PubMed ID: 9032534
[TBL] [Abstract] [Full Text] [Related]
16. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract] [Full Text] [Related]